About Us

OptiGene Limited was formed in 2008 to develop and deliver advanced molecular diagnostics solutions for applications across a range of market sectors. The company is privately owned and is based in Horsham in the South of England, close to Gatwick Airport and within an hour of Heathrow Airport and the centre of London. OptiGene was established with the primary goal of providing the highest quality instrumentation and performance-leading reagents to support isothermal amplification of DNA and RNA. The market pull for this venture came from the growing demands around the world for field testing, rapid results and point-of-care diagnostics.

OptiGene has developed innovative products that support sensitive and specific detection of bacteria and viruses for use in the fields of plant health, food safety, veterinary medicine, environmental monitoring and healthcare. Bio-defence and forensics are also key markets that OptiGene addresses, either directly or through its growing network of international distributors. The company has exploited its expertise in both instrument design and enzymology to develop a sophisticated open platform that will support all isothermal amplification methods. Ultra-sensitive molecular detection that has been constrained to laboratory use by highly-qualified personnel and taking hours to complete can now be deployed to point of application and run with very little training, producing results in single minutes.

The Genie II instrument is the flagship product of OptiGene and has been in full production since the spring of 2011. Genie II is now found in a variety of diagnostic settings around the world. It is supported by specially-designed plastic strips that have lockable caps and that are easy to handle. Enzymes are available in the form of several master mixes that feature combinations of high-speed operation, inherent RT activity and thermostability. A continuous programme of development is maintained at OptiGene in order to satisfy the evolving demands of its customers and the wider market. New instruments are planned that will include a smaller device that will suit on-site use and more sophisticated optical arrangements that can support multiplexed assays. Improvements in the company’s enzymes are on-going with faster and more stable master mixes planned for release. OptiGene can also offer to develop variants of its products on behalf of OEM customers and these can adopt the customer’s corporate branding and include special features.

RoHS Compliance
OptiGene Limited declares that, to the best of our knowledge, all electrical and electronic equipment (EEE) sold by the company are in compliance with Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the restriction of the use of certain hazardous substances in electrical and electronic equipment (also known as “RoHS2”).

REACh Statement
OptiGene Limited also declares that no products sold by the company are known to contain any of the substances of very high concern (SVHC) as intentionally added components with regards to the European Regulation No. 1907/2006 (Registration, Evaluation, Authorisation & restriction of Chemicals).

英国OptiGene Limited声明晟泰勃为其唯一授权代理商点击次数：7111 发布日期：2012-8-9 来源：本站本站原创，转载请注明出处

授权声明

该声明由英国OptiGene Limited和北京晟泰勃科技有限公司联合发布。
发布日期：2012年8月9日

北京晟泰勃科技有限公司为英国OptiGene Limited公司正式授权的在中国地区的代理商。

日前，我们发现个别公司组织及个人未经英国OptiGene Limited公司和北京晟泰勃科技有限公司正式授权，伪称授权销售代理在中国地区推销英国OptiGene Limited公司产品；并虚假宣传散布OptiGene产品原产国信息。OptiGene Limited和北京晟泰勃科技有限公司据其上述行为严正声明如下：

1. 英国OptiGene Limited公司正式授权的中国地区唯一代理商仅为北京晟泰勃科技有限公司，任何其它公司组织或个人的销售活动、所提供技术服务均未获得英国OptiGene Limited和北京晟泰勃科技有限公司的授权。OptiGene Limited公司正式授权代理商信息网址www.optigene.co.uk

2. 北京晟泰勃科技有限公司至今为止没有任何协议授权的经销商。

3. 对于虚假销售代理的销售行为，OptiGene Limited 和北京晟泰勃科技有限公司将不予供货、拒绝提供任何售前及售后服务。

4. 英国OptiGene Limited公司生产的所有产品，全部为自主研发设计生产，其原产国一律为英国本土。

5. 英国OptiGene Limited公司在中国和其它国家没有任何分公司及下属机构。

6. OptiGene Limited 和北京晟泰勃科技有限公司要求未经授权的此类公司组织和个人立即停止所有与OptiGene 产品相关的促销、营销、销售和服务活动，根据中国法律我们将保留对此类违法行为的追诉权力。